RE:RE:RE:RE:RE:Ph2 results
Claridge:
I certainly hope you are wrong in regards to the 3 month data. One of the biggest problems I see with TLT is lack of exposure. If bladder cancer patients see cancer free patients ate 3, 6 and 12 months, they are more likely to enroll, more uroligist will hear about the success and refer more patients. So it helps everyone. Another issue I see if that if they have the 3 month data and do not release it, that will be a major material event they will not be disclosing, also, moat of the time with public companies, no news is bad news. If I was a patient considering certain trials and knew a company had results, but didn't want to disclose them, I would think twice about that their motive is. Waiting for some conference to get better exposure doesn't seem right when you are talking about cancer patients lives. It will also make any insider buys and sales extrmemly questionable. They will be playing with fire if they hold back material information and this company can't afford to burn themselves anymore. I hope they understand this...
G1